It’s like a bad sci-fi movie - despite the devastating effects of the original spike protein, they’re about to be rolled out without human trials. What sort of carnage will occur when your body begins producing three different types?
[embed]https://rumble.com/embed/v1fkmvh/?pub=4[/embed]
STORY AT-A-GLANCE
- August 31, 2022, the U.S. Food and Drug Administration authorized Pfizer’s and Moderna’s bivalent boosters, which will be available to those who have received the primary two-dose series
- Pfizer is releasing a bivalent injection targeting Omicron subvariants BA.4 and BA.5, which are the two currently in circulation. Moderna’s bivalent booster targets the already extinct Wuhan strain and Omicron subvariant BA.1
- The reformulated COVID boosters will be rolled out without safety or effectiveness data from human trials. They’re being green-lighted based on antibody data from mice alone, even though antibody levels tell us nothing about effectiveness
- According to the FDA, the reactogenicity profile of Pfizer’s reformulated shot is “overall similar to prototype BNT162b2 vaccine,” and VAERS data prove that’s hardly a selling point
- This fall, health agencies will also push the seasonal flu shot, and all flu vaccines will be quadrivalent this year, meaning they contain antigens against four influenza strains. Seniors may be at greatest risk for vaccine injury, as they will get a high-dose quadrivalent flu vaccine
